TheraCell announced pending issuance of a U.S. patent for DBF™ demineralized bone fiber, part of AlloSource’s AlloFuse® Cortical Fibers and AlloFuse® Fiber Boats.
AlloFuse products comprise 100% demineralized cortical bone and can be used in a range of spine and orthopaedic procedures.
AlloSource launched AlloFuse Cortical Fiber and Fiber Boat allografts in 2Q16.
Sources: AlloSource; ORTHOWORLD Inc.
TheraCell announced pending issuance of a U.S. patent for DBF™ demineralized bone fiber, part of AlloSource's AlloFuse® Cortical Fibers and AlloFuse® Fiber Boats.
AlloFuse products comprise 100% demineralized cortical bone and can be used in a range of spine and orthopaedic procedures.
AlloSource...
TheraCell announced pending issuance of a U.S. patent for DBF™ demineralized bone fiber, part of AlloSource’s AlloFuse® Cortical Fibers and AlloFuse® Fiber Boats.
AlloFuse products comprise 100% demineralized cortical bone and can be used in a range of spine and orthopaedic procedures.
AlloSource launched AlloFuse Cortical Fiber and Fiber Boat allografts in 2Q16.
Sources: AlloSource; ORTHOWORLD Inc.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.






